Luis
Madero Lopez
Institute Curie
París, FranciaPublications en collaboration avec des chercheurs de Institute Curie (1)
2013
-
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: A joint ITCC and SIOPE brain tumor study
Neuro-Oncology, Vol. 15, Núm. 9, pp. 1236-1243